[医学咨询和神经心理测试]。

Q4 Medicine
Hideharu Karasawa
{"title":"[医学咨询和神经心理测试]。","authors":"Hideharu Karasawa","doi":"10.11477/mf.030126030530050884","DOIUrl":null,"url":null,"abstract":"<p><p>We are now in an era where neurosurgeons play an active role in the treatment of dementia. One of the most effective ways to gather essential clinical information during the initial consultation is through a structured questionnaire. This helps establish a comprehensive picture of the patient's condition, supports differential diagnosis, and aids in assessing disease severity. With the advent of anti-amyloid-beta antibody therapies, it is now possible to offer targeted treatment for certain types of dementia. Eligibility criteria for administration include a Mini Mental State Examination score of 22-30 for Rekenbi<sup>®</sup> and 20-28 for Kesanra<sup>®</sup>, measured within one month prior to treatment initiation. Additionally, patients should have a Clinical Dementia Rating of 0.5 or 1.</p>","PeriodicalId":35984,"journal":{"name":"Neurological Surgery","volume":"53 5","pages":"884-892"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Medical Consultations and Neuropsychological Tests].\",\"authors\":\"Hideharu Karasawa\",\"doi\":\"10.11477/mf.030126030530050884\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>We are now in an era where neurosurgeons play an active role in the treatment of dementia. One of the most effective ways to gather essential clinical information during the initial consultation is through a structured questionnaire. This helps establish a comprehensive picture of the patient's condition, supports differential diagnosis, and aids in assessing disease severity. With the advent of anti-amyloid-beta antibody therapies, it is now possible to offer targeted treatment for certain types of dementia. Eligibility criteria for administration include a Mini Mental State Examination score of 22-30 for Rekenbi<sup>®</sup> and 20-28 for Kesanra<sup>®</sup>, measured within one month prior to treatment initiation. Additionally, patients should have a Clinical Dementia Rating of 0.5 or 1.</p>\",\"PeriodicalId\":35984,\"journal\":{\"name\":\"Neurological Surgery\",\"volume\":\"53 5\",\"pages\":\"884-892\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurological Surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.11477/mf.030126030530050884\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurological Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11477/mf.030126030530050884","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

我们现在处于神经外科医生在痴呆症治疗中发挥积极作用的时代。在初次会诊期间收集基本临床信息的最有效方法之一是通过结构化问卷。这有助于全面了解患者的病情,支持鉴别诊断,并有助于评估疾病的严重程度。随着抗淀粉样蛋白抗体疗法的出现,现在有可能为某些类型的痴呆症提供靶向治疗。给药资格标准包括Rekenbi®的迷你精神状态检查分数为22-30,Kesanra®的20-28,在治疗开始前一个月内测量。此外,患者的临床痴呆评分应为0.5或1。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Medical Consultations and Neuropsychological Tests].

We are now in an era where neurosurgeons play an active role in the treatment of dementia. One of the most effective ways to gather essential clinical information during the initial consultation is through a structured questionnaire. This helps establish a comprehensive picture of the patient's condition, supports differential diagnosis, and aids in assessing disease severity. With the advent of anti-amyloid-beta antibody therapies, it is now possible to offer targeted treatment for certain types of dementia. Eligibility criteria for administration include a Mini Mental State Examination score of 22-30 for Rekenbi® and 20-28 for Kesanra®, measured within one month prior to treatment initiation. Additionally, patients should have a Clinical Dementia Rating of 0.5 or 1.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Neurological Surgery
Neurological Surgery Medicine-Medicine (all)
自引率
0.00%
发文量
99
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信